Genomic data with clinical outcome data from routine practice data from The Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA
Initiatives
-
Columbia University Irving Medical Center uses the Illumina TruSeq Amplicon – Cancer Panel (TSACP) to detect known cancer hotspots.
* Provide oversight and infrastructure for the development and maintenance of cancer-related clinical databases and biobanks for collection of data and biospecimens.
* Enable linkage to clinical data and tumor registry data through a secure portal.
* To procure and maintain a repository of human biological samples, clinical data and epidemiologic data for distribution to investigators, while also protecting the confidentiality of individuals donating to the repository in the course of their medical care and/or research participation.
Visit COLU
Investigators | Contacts |
---|---|
|
Design
- Study design
- Patients' cohort
Recruitment
- Sources of Recruitment
-
- Individuals
Number of participants
- Number of participants
- Number of participants with biosamples
Access
Availability of data and biosamples
Data | |
Biosamples | |
Other |
Availability of access information
By contacting the study representative